lct under valued for quite long time already ..

pls pm me too:)

inno the best but smaller company

sop swkplnt taan all good...kmloong good div n cash

time to move further..

very good prospect from boss at EGM, refer above ..

asp Q3 increase >20% from Q2 , asp Q4 increase >40% from Q3 @_@

..mentioned "very very very well" for next year :)

very good prospect from boss Mr Lim :)

EGM today 10.30am

kossan will be better in terms of value ..

bravo everyday!

good ..

close highest 0.55 cantik!

bravo!

HUAT ..

good!

good!

good boss ..

keep n wait ..

kossan day .. bravo!

downside is very limited

so kossan is a safe play all the time ..

kossan always let the kanciong one up first.. then will follow safely ..

kossan will up tomoro..:}

at least worth rm14

buy kossan ..

buy ..

trust the reliable n steady company - KOSSAN

just buy n hold for medium to long term ..

kossan is the cheapest n good value compares to others:)

buy kossan .. :)

We wish to announce that the operations of our 40% associate company, Lotte Chemical USA Corporation's (“LC USA”) petrochemical facility located in Lake Charles, Louisiana was disrupted due to Hurricane Laura which swept through the locality between 25 August 2020 to 31 August 2020.

The Company is of the view that this incident has no material effect on the Company’s financial condition.

This announcement is dated 7 September 2020

buy .. 101 .. :)

keep ..

keep ..

buy

..buy ..

buy ..

good serba ..

bplant first ..

https://klse.i3investor.com/blogs/philip2/2020-09-02-story-h1513287530-Why_I_invested_in_Serba_Dinamik_Kpowers_and_SCIB.jsp

https://klse.i3investor.com/blogs/philip2/2020-09-02-story-h1513287530-Why_I_invested_in_Serba_Dinamik_Kpowers_and_SCIB.jsp

good Philip

time will tell ..

today must close high ..

good opportunity ..

accumulate lo :)

buy .. :)

Just a myth. Contrary to popular belief, pharmaceutical companies like ApexH are also faced with an uncertain outlook for 2H2020 due to disruptions caused by the pandemic. Weaker consumer sentiment and cautious spending has impacted ApexH’s sales, while the deferment elective medical procedures like orthopaedic surgeries has resulted in lower demand for Straits Apex’s orthopaedic devices. However, during this tough time, ApexH has also completed its cold chain distribution expansion in Singapore, while the expansion in Malaysia is expected to complete in 4QFY20. Given that cold chain distribution is vital for the distribution of vaccine, we are positive on this timely expansion as ApexH would be able to expand into vaccine distribution, be it a Covid-19 vaccine or other vaccines available. However, contrary to market’s belief, we are not expecting immediate benefit arising from any potential vaccine distribution by Apex
Source: PublicInvest Research - 27 Aug 2020